171 related articles for article (PubMed ID: 11001886)
1. Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance.
Eichler P; Friesen HJ; Lubenow N; Jaeger B; Greinacher A
Blood; 2000 Oct; 96(7):2373-8. PubMed ID: 11001886
[TBL] [Abstract][Full Text] [Related]
2. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.
Greinacher A; Janssens U; Berg G; Böck M; Kwasny H; Kemkes-Matthes B; Eichler P; Völpel H; Pötzsch B; Luz M
Circulation; 1999 Aug; 100(6):587-93. PubMed ID: 10441094
[TBL] [Abstract][Full Text] [Related]
3. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.
Greinacher A; Völpel H; Janssens U; Hach-Wunderle V; Kemkes-Matthes B; Eichler P; Mueller-Velten HG; Pötzsch B
Circulation; 1999 Jan 5-12; 99(1):73-80. PubMed ID: 9884382
[TBL] [Abstract][Full Text] [Related]
4. Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies.
Mudaliar JH; Liem TK; Nichols WK; Spadone DP; Silver D
J Vasc Surg; 2001 Jul; 34(1):17-20. PubMed ID: 11436069
[TBL] [Abstract][Full Text] [Related]
5. Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3.
Lubenow N; Eichler P; Lietz T; Greinacher A;
J Thromb Haemost; 2005 Nov; 3(11):2428-36. PubMed ID: 16241940
[TBL] [Abstract][Full Text] [Related]
6. Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.
Harenberg J; Jörg I; Fenyvesi T; Piazolo L
J Thromb Thrombolysis; 2005 Feb; 19(1):65-9. PubMed ID: 15976970
[TBL] [Abstract][Full Text] [Related]
7. A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia.
Farner B; Eichler P; Kroll H; Greinacher A
Thromb Haemost; 2001 Jun; 85(6):950-7. PubMed ID: 11434701
[TBL] [Abstract][Full Text] [Related]
8. Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevance.
Greinacher A; Eichler P; Albrecht D; Strobel U; Pötzsch B; Eriksson BI
Blood; 2003 Apr; 101(7):2617-9. PubMed ID: 12393696
[TBL] [Abstract][Full Text] [Related]
9. Excessive anticoagulation and anaphylactic reaction after rechallenge with lepirudin in a patient with heparin-induced thrombocytopenia.
Badger NO; Butler K; Hallman LC
Pharmacotherapy; 2004 Dec; 24(12):1800-3. PubMed ID: 15585446
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range.
Greinacher A; Eichler P; Lubenow N; Kwasny H; Luz M
Blood; 2000 Aug; 96(3):846-51. PubMed ID: 10910895
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
Dang CH; Durkalski VL; Nappi JM
Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
[TBL] [Abstract][Full Text] [Related]
12. Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies.
Lubenow N; Eichler P; Lietz T; Farner B; Greinacher A
Blood; 2004 Nov; 104(10):3072-7. PubMed ID: 15280202
[TBL] [Abstract][Full Text] [Related]
13. The use of ecarin chromogenic assay and prothrombinase induced clotting time in the monitoring of lepirudin for the treatment of heparin-induced thrombocytopenia.
Guy S; Kitchen S; Laidlaw S; Cooper P; Woolley A; Maclean R
Br J Haematol; 2008 Jul; 142(3):466-8. PubMed ID: 18510685
[TBL] [Abstract][Full Text] [Related]
14. Re-exposure to recombinant (r)-hirudin in antihirudin antibody-positive patients with a history of heparin-induced thrombocytopenia.
Harenberg J; Huhle G; Wang LC; Hoffmann U; Song XH
Br J Haematol; 2000 May; 109(2):360-3. PubMed ID: 10848825
[TBL] [Abstract][Full Text] [Related]
15. Hirudin in heparin-induced thrombocytopenia.
Lubenow N; Greinacher A
Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
[TBL] [Abstract][Full Text] [Related]
16. Continuous haemofiltration with r-hirudin (lepirudin) as anticoagulant in a patient with heparin induced thrombocytopenia (HIT II).
Schneider T; Heuer B; Deller A; Boesken WH
Wien Klin Wochenschr; 2000 Jun; 112(12):552-5. PubMed ID: 10953874
[TBL] [Abstract][Full Text] [Related]
17. The management of heparin-induced thrombocytopenia.
Keeling D; Davidson S; Watson H;
Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
Kiser TH; Jung R; MacLaren R; Fish DN
Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
[TBL] [Abstract][Full Text] [Related]
19. Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation.
Dager WE; Gosselin RC; Yoshikawa R; Owings JT
Ann Pharmacother; 2004 Apr; 38(4):598-601. PubMed ID: 14982973
[TBL] [Abstract][Full Text] [Related]
20. Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis.
Dager WE; White RH
Ann Pharmacother; 2001; 35(7-8):885-90. PubMed ID: 11485140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
